Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial.
Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, Gasbarrini A, Hébuterne X, Arnesson K, Knittel T, Kowalski J, Neurath MF, Sandborn WJ, Reinisch W; CONDUCT study group. Atreya R, et al. Among authors: gasbarrini a. Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1063-1075. doi: 10.1016/S2468-1253(20)30301-0. Epub 2020 Oct 5. Lancet Gastroenterol Hepatol. 2020. PMID: 33031757 Clinical Trial.
A phase II study of laquinimod in Crohn's disease.
D'Haens G, Sandborn WJ, Colombel JF, Rutgeerts P, Brown K, Barkay H, Sakov A, Haviv A, Feagan BG; Laquinimod for Crohn's Disease Investigators. D'Haens G, et al. Gut. 2015 Aug;64(8):1227-35. doi: 10.1136/gutjnl-2014-307118. Epub 2014 Oct 3. Gut. 2015. PMID: 25281416 Free PMC article. Clinical Trial.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.
Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brünnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Müllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V; RELIEF study group. Bañares R, et al. Among authors: gasbarrini a. Hepatology. 2013 Mar;57(3):1153-62. doi: 10.1002/hep.26185. Epub 2013 Feb 15. Hepatology. 2013. PMID: 23213075 Clinical Trial.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 May;35(5):448-457. doi: 10.1016/j.annonc.2024.02.005. Epub 2024 Feb 19. Ann Oncol. 2024. PMID: 38382875 Free article. Clinical Trial.
Overview of Molecular Prognostication for Common Solid Tumor Histologies - What the Surgeon Should Know.
Goodwin CR, De la Garza Ramos R, Bettegowda C, Barzilai O, Shreyaskumar P, Fehlings MG, Laufer I, Sahgal A, Rhines LD, Reynolds JJ, Lazary A, Gasbarrini A, Dea N, Verlaan JJ, Sullivan PZ, Gokaslan ZL, Fisher CG, Boriani S, Shin JH, Hornicek FJ, Weber MH, Goodwin ML, Charest-Morin R; AO Spine Knowledge Forum Tumor. Goodwin CR, et al. Among authors: gasbarrini a. Global Spine J. 2025 Jan;15(1_suppl):6S-15S. doi: 10.1177/21925682241250327. Global Spine J. 2025. PMID: 39801124 Free PMC article.
Risk Factors for the Development of Neurological Deficits in Metastatic Spinal Disease: An International, Multicenter Delphi Study.
Huele EH, Gal R, Eppinga WSC, Verkooijen HM, O'Toole JE, Laufer I, Sciubba DM, Netzer C, Foppen W, Sahgal A, Fehlings MG, Lo SL, Fisher CG, Rhines LD, Reynolds JJ, Lazary A, Gasbarrini A, Dea N, Weber MH, Verlaan JJ. Huele EH, et al. Among authors: gasbarrini a. Global Spine J. 2025 Jan;15(1_suppl):93S-103S. doi: 10.1177/21925682231222424. Global Spine J. 2025. PMID: 39801123 Free PMC article.
Advanced Radiotherapy Technologies in Spine Tumors: What the Surgeon Needs to Know.
Chen H, Ghia AJ, Maralani PJ, Bettegowda C, Boriani S, Dea N, Fisher CG, Gasbarrini A, Gokaslan ZL, Laufer I, Lazary A, Reynolds J, Verlaan JJ, Rhines LD, Sahgal A. Chen H, et al. Among authors: gasbarrini a. Global Spine J. 2025 Jan;15(1_suppl):104S-119S. doi: 10.1177/21925682241229665. Global Spine J. 2025. PMID: 39801121 Free PMC article.
Prevention and Management of Posterior Wound Complications Following Oncologic Spine Surgery: Narrative Review of Available Evidence and Proposed Clinical Decision-Making Algorithm.
Leary OP, Setty A, Gong JH, Ali R, Fridley JS, Fisher CG, Sahgal A, Rhines LD, Reynolds JJ, Lazáry Á, Laufer I, Gasbarrini A, Dea N, Verlaan JJ, Bettegowda C, Boriani S, Mesfin A, Luzzati A, Shin JH, Cecchinato R, Hornicek FJ, Goodwin ML, Gokaslan ZL. Leary OP, et al. Among authors: gasbarrini a. Global Spine J. 2025 Jan;15(1_suppl):143S-156S. doi: 10.1177/21925682241237486. Global Spine J. 2025. PMID: 39801119 Free PMC article.
Latest Developments in Targeted Biological Therapies in the Management of Chordoma and Chondrosarcoma.
Biczo A, Sahgal A, Verlaan JJ, Shreyaskumar P, Szoverfi Z, Schultheiss M, Rhines L, Reynolds J, Laufer I, Gasbarrini A, Dea N, Gokaslan Z, Fisher C, Bettegowda C, Boriani S, Hornicek F, Goodwin R, Lazary A. Biczo A, et al. Among authors: gasbarrini a. Global Spine J. 2025 Jan;15(1_suppl):120S-131S. doi: 10.1177/21925682241227917. Global Spine J. 2025. PMID: 39801117 Free article.
1,816 results